Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya
Background: Cholera remains a public health challenge in Kenya. To better understand its dynamics, we analyzed <i>Vibrio cholerae</i> genomes from clinical and environmental samples collected during the 2022–2023 outbreak. These strains were compared with historical genomes from Kenya, Uganda, Tanza...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Language: | Inglés |
| Published: |
Frontiers Media
2025
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10568/175537 |
| _version_ | 1855537323227217920 |
|---|---|
| author | Mageto, L.M. Aboge, G.O. Mekuria, Z.H. Gathura, P. Juma, John Mugo, M. Kebenei, C.K. Imoli, D. Ongadi, B.A. Kering, K. Mbae, C.K. Kariuki, S. |
| author_browse | Aboge, G.O. Gathura, P. Imoli, D. Juma, John Kariuki, S. Kebenei, C.K. Kering, K. Mageto, L.M. Mbae, C.K. Mekuria, Z.H. Mugo, M. Ongadi, B.A. |
| author_facet | Mageto, L.M. Aboge, G.O. Mekuria, Z.H. Gathura, P. Juma, John Mugo, M. Kebenei, C.K. Imoli, D. Ongadi, B.A. Kering, K. Mbae, C.K. Kariuki, S. |
| author_sort | Mageto, L.M. |
| collection | Repository of Agricultural Research Outputs (CGSpace) |
| description | Background: Cholera remains a public health challenge in Kenya. To better understand its dynamics, we analyzed <i>Vibrio cholerae</i> genomes from clinical and environmental samples collected during the 2022–2023 outbreak. These strains were compared with historical genomes from Kenya, Uganda, Tanzania, and Haiti to inform strategies for cholera prevention, control, and elimination in Kenya.
Methods: Clinical (stool) and environmental (wastewater, drinking water, and household effluent) samples were collected from Nairobi county. Samples were analyzed for <i>V. cholerae</i> using culture and real time PCR. The environmental (n = 17) and clinical (n = 70) isolates were then subjected to phenotypic antimicrobial susceptibility testing using the Kirby-Bauer disk diffusion method. Whole genome sequencing was employed to characterize the genome, detect antimicrobial resistance genes, virulence factors, and mobile genetic elements. Phylogenetic analysis was performed to assess the genetic relationship and diversity of isolates from 2022 to 2023 outbreak, comparing them with isolates from historical outbreaks.
Results: Clinical isolates carried key virulence genes (<i>ctxA</i>, <i>ctxB7</i>, <i>zot</i>, and <i>hlyA</i>) and were 100% resistant to multiple antibiotics, including ampicillin, cefotaxime, ceftriaxone, and cefpodoxime, but remained susceptible to gentamicin and chloramphenicol. In contrast, environmental isolates lacked <i>ctxB</i> gene but harbored <i>toxR</i>, <i>als</i>, and <i>hlyA</i>, showing variable antibiotic resistance (59% to ampicillin, 41% to trimethoprim-sulfamethoxazole, and 47% to nalidixic acid). All clinical isolates from 2022 to 2023 outbreak harbored IncA/C2 plasmids and several antimicrobial resistance genes including <i>bla<sub>PER–7</sub></i>. Phylogenetic analysis revealed high genetic diversity in environmental strains, clustering outside the 7th pandemic El Tor lineage, while clinical isolates were highly clonal. Genomes from 2022 to 2023 outbreak were closely related to Kenyan cholera outbreak genomes from 2016 (15 single nucleotide polymorphisms, T13 lineage).
Conclusion: The 2022–2023 outbreak likely resulted from re-emergence of previously circulating strains rather than a new introduction. While the role of environmental reservoirs as a source of human infection remains unclear in our study, environmental isolates possess virulent and antimicrobial resistance genes that may spread via horizontal gene transfer. This highlights the need for continuous genomic surveillance to monitor <i>V. cholerae</i> evolution, track transmission patterns, and mitigate the spread of antimicrobial resistance. |
| format | Journal Article |
| id | CGSpace175537 |
| institution | CGIAR Consortium |
| language | Inglés |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | Frontiers Media |
| publisherStr | Frontiers Media |
| record_format | dspace |
| spelling | CGSpace1755372025-12-08T10:29:22Z Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya Mageto, L.M. Aboge, G.O. Mekuria, Z.H. Gathura, P. Juma, John Mugo, M. Kebenei, C.K. Imoli, D. Ongadi, B.A. Kering, K. Mbae, C.K. Kariuki, S. cholera genomics health Background: Cholera remains a public health challenge in Kenya. To better understand its dynamics, we analyzed <i>Vibrio cholerae</i> genomes from clinical and environmental samples collected during the 2022–2023 outbreak. These strains were compared with historical genomes from Kenya, Uganda, Tanzania, and Haiti to inform strategies for cholera prevention, control, and elimination in Kenya. Methods: Clinical (stool) and environmental (wastewater, drinking water, and household effluent) samples were collected from Nairobi county. Samples were analyzed for <i>V. cholerae</i> using culture and real time PCR. The environmental (n = 17) and clinical (n = 70) isolates were then subjected to phenotypic antimicrobial susceptibility testing using the Kirby-Bauer disk diffusion method. Whole genome sequencing was employed to characterize the genome, detect antimicrobial resistance genes, virulence factors, and mobile genetic elements. Phylogenetic analysis was performed to assess the genetic relationship and diversity of isolates from 2022 to 2023 outbreak, comparing them with isolates from historical outbreaks. Results: Clinical isolates carried key virulence genes (<i>ctxA</i>, <i>ctxB7</i>, <i>zot</i>, and <i>hlyA</i>) and were 100% resistant to multiple antibiotics, including ampicillin, cefotaxime, ceftriaxone, and cefpodoxime, but remained susceptible to gentamicin and chloramphenicol. In contrast, environmental isolates lacked <i>ctxB</i> gene but harbored <i>toxR</i>, <i>als</i>, and <i>hlyA</i>, showing variable antibiotic resistance (59% to ampicillin, 41% to trimethoprim-sulfamethoxazole, and 47% to nalidixic acid). All clinical isolates from 2022 to 2023 outbreak harbored IncA/C2 plasmids and several antimicrobial resistance genes including <i>bla<sub>PER–7</sub></i>. Phylogenetic analysis revealed high genetic diversity in environmental strains, clustering outside the 7th pandemic El Tor lineage, while clinical isolates were highly clonal. Genomes from 2022 to 2023 outbreak were closely related to Kenyan cholera outbreak genomes from 2016 (15 single nucleotide polymorphisms, T13 lineage). Conclusion: The 2022–2023 outbreak likely resulted from re-emergence of previously circulating strains rather than a new introduction. While the role of environmental reservoirs as a source of human infection remains unclear in our study, environmental isolates possess virulent and antimicrobial resistance genes that may spread via horizontal gene transfer. This highlights the need for continuous genomic surveillance to monitor <i>V. cholerae</i> evolution, track transmission patterns, and mitigate the spread of antimicrobial resistance. 2025-07-07 2025-07-08T04:26:53Z 2025-07-08T04:26:53Z Journal Article https://hdl.handle.net/10568/175537 en Open Access Frontiers Media Mageto, L.M., Aboge, G.O., Mekuria, Z.H., Gathura, P., Juma, J., Mugo, M., Kebenei, C.K., Imoli, D., Ongadi, B.A., Kering, K., Mbae, C.K. and Kariuki, S. 2025. Genomic characterization of <i>Vibrio cholerae</i> isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya. Frontiers in Microbiology 16: 1603736. |
| spellingShingle | cholera genomics health Mageto, L.M. Aboge, G.O. Mekuria, Z.H. Gathura, P. Juma, John Mugo, M. Kebenei, C.K. Imoli, D. Ongadi, B.A. Kering, K. Mbae, C.K. Kariuki, S. Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title | Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title_full | Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title_fullStr | Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title_full_unstemmed | Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title_short | Genomic characterization of Vibrio cholerae isolated from clinical and environmental sources during the 2022–2023 cholera outbreak in Kenya |
| title_sort | genomic characterization of vibrio cholerae isolated from clinical and environmental sources during the 2022 2023 cholera outbreak in kenya |
| topic | cholera genomics health |
| url | https://hdl.handle.net/10568/175537 |
| work_keys_str_mv | AT magetolm genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT abogego genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT mekuriazh genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT gathurap genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT jumajohn genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT mugom genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT kebeneick genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT imolid genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT ongadiba genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT keringk genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT mbaeck genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya AT kariukis genomiccharacterizationofvibriocholeraeisolatedfromclinicalandenvironmentalsourcesduringthe20222023choleraoutbreakinkenya |